Here’s What Analysts Are Saying About Bristol-Myers Squibb Company (BMY)
Bristol-Myers Squibb Company (NYSE:BMY) is one of the best medical research stocks to buy according to hedge funds.
Insider Monkey Blog
Where is Regeneron Pharmaceuticals (REGN) Headed According to Analysts?
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is one of the best medical research stocks to buy according to hedge funds.
Is Pfizer Inc. (PFE) One of the Best Medical Research Stocks to Buy According to Hedge Funds?
Pfizer Inc. (NYSE:PFE) is one of the best medical research stocks to buy according to hedge funds. Pfizer Inc. (NYSE:PFE) announced on February 6 that the U.S.
Merck & Co. (MRK) Announces FDA Approval of KEYTRUDA® and KEYTRUDA QLEX™ Plus Paclitaxel, With or Without Bevacizumab, to Treat Adults With PD-L1+
Merck & Co., Inc. (NYSE:MRK) is one of the best medical research stocks to buy according to hedge funds. Merck & Co., Inc.
Where is AbbVie Inc. (ABBV) Headed According to the Street?
AbbVie Inc. (NYSE:ABBV) is one of the best medical research stocks to buy according to hedge funds. AbbVie Inc.
Why is Johnson & Johnson (JNJ) One of the Best Medical Research Stocks to Buy According to Hedge Funds?
Johnson & Johnson (NYSE:JNJ) is one of the best medical research stocks to buy according to hedge funds.
Eli Lilly and Company (LLY) Gets Upgraded to Buy From Hold by Freedom Capital
Eli Lilly and Company (NYSE:LLY) is one of the best medical research stocks to buy according to hedge funds.
13 Best Upside Stocks to Invest In Right Now
On February 10, Sam Stovall, chief investment strategist at CFRA, and Tim Seymour, founder of Seymour Asset Management, appeared on CNBC’s 'Closing Bell Overtime' to discuss...
KeyBanc Raises Monolithic Power Systems (MPWR) Price Target on Record Quarterly Revenue
Monolithic Power Systems, Inc. (NASDAQ:MPWR) ranks among the best high growth high margin stocks to buy now.
Royal Caribbean (RCL) Named Best-in-Class Cruise Operator by JPMorgan
Royal Caribbean Cruises Ltd. (NYSE:RCL) ranks among the best high growth high margin stocks to buy now. On January 29, Royal Caribbean Cruises Ltd.
CIBC Boosts Agnico Eagle (AEM) Target on Strong Gold Price Forecast
Agnico Eagle Mines Limited (NYSE:AEM) ranks among the best high growth high margin stocks to buy now.
Vertex Pharma (VRTX) Renal Pipeline Seen as Major Growth Driver by Barclays
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) ranks among the best high growth high margin stocks to buy now.
Coinbase (COIN) Seen as Strong Crypto Franchise by Baird, Starts Coverage With Neutral Rating
Coinbase Global Inc. (NASDAQ:COIN) ranks among the best high growth high margin stocks to buy now. On January 28, Baird began coverage of Coinbase Global Inc.
Robinhood (HOOD) Stock Selloff May Be Overblown, Said Truist
Robinhood Markets Inc. (NASDAQ:HOOD) ranks among the best high growth high margin stocks to buy now. Truist Securities reduced its price target for Robinhood Markets Inc.
Analysts Highlight Palantir’s (PLTR) Unique Software Financial Profile
Palantir Technologies Inc. (NASDAQ:PLTR) ranks among the best high growth high margin stocks to buy now.
Deutsche Bank Bullish on AppLovin (APP) After Sharp Pullback Following Project Genie Announcement
AppLovin Corporation (NASDAQ:APP) ranks among the best high growth high margin stocks to buy now.
Eli Lilly (LLY) Retains Buy Rating on Strong 2026 Outlook
Eli Lilly & Company (NYSE:LLY) ranks among the best high growth high margin stocks to buy now.
Goldman Sachs Expects Beat and Raise Quarter for NVIDIA (NVDA)
NVIDIA Corporation (NASDAQ:NVDA) ranks among the best high growth high margin stocks to buy now.
11 Most Undervalued Mid Cap Stocks to Buy Now
On January 27, Matt Stucky of Northwestern Mutual joined 'Closing Bell Overtime' on CNBC to discuss the shifting dynamics of the 2026 stock market and the broadening of investor...
Roth Capital Upgrades Roblox (RBLX) to Buy
On February 9, Roth Capital upgraded its recommendation on Roblox to a Buy (from Neutral) and bumped up its target price on the stock by 7.7% to $84 (from $78).
TD Cowens Cuts Target on e.l.f. Beauty (ELF) to $100
On February 9, TD Cowen trimmed its target price on e.l.f. Beauty by 9.1% to $100 (from $110), while retaining its Buy recommendation on the stock.
Guggenheim Raises Target on Praxis Precision Medicines (PRAX) to $800
Guggenheim, on February 10, raised its target price on Praxis Precision (PRAX) by 5.3% to $800 (from $760) and reiterated its Buy recommendation on the stock.
Mizuho Trims Target Price on Affirm (AFRM) to $95
On February 9, Mizuho reduced its target price on Affirm Holdings by 16.7% to $95 (from $114) while keeping an Outperform call on the stock.
William Blair Initiates Coverage on Dave (DAVE)
Andrew Jeffery, analyst at William Blair, initiated the firm’s coverage of Dave Inc. (DAVE) on February 9, with an Outperform call.
Clear Street Trims Price Target on CleanSpark (CLSK) to $22, as Bitcoin Prices Fall
On February 9, Clear Street trimmed its target price on CleanSpark by 18.5% to $22 (from $27) but retained its Buy recommendation on the stock.
Bernstein Trims Target Price on Oracle (ORCL) to $313
Bernstein, on February 9, trimmed its target price on Oracle by 7.7% to $313 (from $339), but retained its Outperform call on the stock.
JP Morgan Reduces Price Target on Spotify (SPOT) to $700
On February 11, JPMorgan trimmed its target price on Spotify by 13.0% to $700 from $805, while retaining an Overweight call on the stock.
Wedbush Cuts Target Price on Unity (U) to $30, Due to AI Concerns
On February 12, Wedbush cut its target price on Unity Software by 18.9% to $30 (from $37) but maintained an Outperform rating on the stock.
Roth Capital Cuts TP on Credo Technology (CRDO) to $200
Roth Capital cut its target price on Credo Technology on February 10 by 20.0% to $200 (from $250) but retained its Buy recommendation on the stock.
WellsFargo Upgrades GeneDx (WGS) to Overweight
WellsFargo upgraded its rating on GeneDX to Overweight (from Equal Weight) on February 9, while retaining the target price at $155.
Goldman Sachs Reduces Target Price on Galaxy Digital (GLXY) to $24, due to Weak Q4 Numbers
On February 4, Goldman Sachs trimmed its target price on Galaxy Digital by 11.1% to $24 (from $27) and retained its Neutral call on the stock.
Strategy Inc, (MSTR) Swings to a Loss in Q4 due to Mark-to-Market Bitcoin Losses
On February 5, MSTR released its Q4-2025 earnings report, which delivered mixed results relative to analyst expectations. Revenue grew 1.9% YoY to $123.0 million (vs.
STARTRADER Presents Its Post-Rebrand Vision at iFX EXPO Dubai 2026
The event, organized by Ultimate Fintech, is a platform that serves as a great networking point.
PU Prime Secures CMA Licence in UAE, Expanding Its Global Regulatory Footprint
PU Prime, a leading global multi-asset broker group, is proud to announce that its Dubai-based entity has officially been granted a licence by the Capital Market Authority (CMA...
IUX Announces “Your Edge, Optimized” 2026 Strategic Pivot, 10th Anniversary Roadmap and Product Launches
IUX, a global leader in high-performance trading technology, today officially launched its 2026 flagship campaign, "IUX Your edge, Optimized." The announcement marks a definitive...
Hola Prime Wins “Fastest Payout Prop Firm – MEA 2026” And Publishes the Operational Data Behind It
Hola Prime has been named “Fastest Payout Prop Firm – MEA 2026” at the Ultimate Fintech (UF) Awards MEA during iFX EXPO Dubai, one of the region’s leading fintech and ...
TD Cowen Presented a Bullish Stance on Franklin Resources (BEN)
On February 2, TD Cowen’s Bill Katz raised his price recommendation on Franklin Resources, Inc. (NYSE:BEN) to $36 from $30. The analyst kept a Hold rating in place.
FactSet (FDS) Target Lowered by Wells Fargo Amid AI Concerns in Info Services
On February 4, Wells Fargo cut its price target on FactSet Research Systems Inc. (NYSE:FDS) to $215 from $265 and maintained an Underweight rating.
BMO Lifts Chubb (CB) Target After Q4, Flags Reserve and Investment Income Tailwinds
On February 10, BMO Capital’s Michael Zaremski revisited his outlook on Chubb Limited (NYSE:CB) following the company’s Q4 results, raising his price recommendation to $326...
11 Most Promising Low-Cost Stocks to Buy Now
On February 7, Richard Bernstein, CEO of Richard Bernstein Advisors, joined 'The Exchange' on CNBC to discuss the state of equity markets, assessing which stocks are growing fast...
Bank of America Reaffirms Buy on Amcor (AMCR), Raises Target to $56
On February 4, Bank of America lifted its price recommendation on Amcor plc (NYSE:AMCR) to $56 from $48.40. The firm also reiterated its Buy rating on the stock.
Stifel Cuts Essex Property Trust (ESS) PT to $278 After Q4 Review, Keeps Hold
On February 5, Stifel trimmed its price recommendation on Essex Property Trust, Inc. (NYSE:ESS) to $278 from $290.75. It reiterated a Hold rating on the stock.
Citi Raises Becton Dickinson (BDX) PT to $198 after Life Sciences Sale Update
On February 11, Citi analyst Joanne Wuensch lifted her price recommendation on Becton, Dickinson and Company (NYSE:BDX) to $198 from $185.70 and maintained a Buy rating.
Brown & Brown (BRO) Announces Accelerated Share Repurchase, Flags Evolving Market Trends
On February 12, Brown & Brown, Inc. (NYSE:BRO) announced the launch of a $250 million accelerated share repurchase program with Bank of America, N.A.
Hedge Fund Investor Letters Q4 2025
We will be sharing Q4 2025 hedge fund investor letters in this article.
Goldman Sachs Raises Stanley Black & Decker (SWK) PT to $84 After Margin-Driven Q4 Beat
On February 6, Goldman Sachs analyst Joe Ritchie raised his price recommendation on Stanley Black & Decker, Inc. (NYSE:SWK) to $84 from $78.
Needham Upgrades Medtronic (MDT) to Buy, Sets $121 PT on Product Launch Momentum
On February 9, Needham & Company upgraded Medtronic plc (NYSE:MDT) to Buy from Hold. It set a $121 price target on the stock.
11 Best Strong Buy Penny Stocks to Invest In
On February 12, Wolfe Research’s Chris Senyek joined CNBC’s ‘Power Lunch’ to discuss the state of equity markets.
Stephens Cuts Hormel (HRL) PT to $25, Sees Near-Term Margin Pressure Despite 2026 Improvement
On February 11, Stephens trimmed its price recommendation on Hormel Foods Corporation (NYSE:HRL) to $25 from $27. It maintained an Equal Weight rating on the stock.
BMO Lifts Archer-Daniels-Midland (ADM) Target After Q4, Says EPS Still Needs to Catch Up
On February 4, BMO Capital’s Andrew Strelzik lifted his price recommendation on Archer-Daniels-Midland Company (NYSE:ADM) to $63 from $57 following the company’s fourth-quarter...
Hedge Fund Resource Center
